Business Daily from THE HINDU group of publications
Sunday, Sep 17, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Health
Stem-cells research and therapy on armed forces' radar

Our Bureau

Mumbai , Sept. 16

Stem-cell research and therapy is on the radar of the armed forces. The Mumbai-based Navy Hospital, INHS Asvini, has started using stem-cell treatment in adults, Surgeon Vice-Admiral V.K. Singh, Director General, Armed Forces Medical Services, has said . Stem-cell treatment is used in indications such as blood disorders, cancers, and cardiac disorders.

While stem-cell treatment has been undertaken in the Army's R&R Hospital in Delhi for sometime now, he told newspersons that Pune's Armed Forces Medical College will commence a similar research and therapy by December. Three other centres in Pune, Bangalore and Kolkata are also slated to undertake stem-cell research and therapies soon, he said.

Embryonic stem-cell research is not currently being undertaken at the Navy Hospitalin Mumbai due to the ban on the same, he said. However, given that the future may allow embryonic stem-cell research, preparations were being made for stem-cell and cord-blood banks, he added.

Stem-cells are unspecialised cells that can be coaxed into developing like other cells in the body, such as the heart cells, brain and blood. And sections of the scientific community see such research providing a breakthrough in illnesses such as Parkinson's, Alzheimer's and cancer.

However, embryonic stem-cell research evokes strong ethical debates, since cells are got from foetal tissues.

A conference on `Stem-cells in War and Peace' is scheduled to take place at INHS Asvini on September 17. Meanwhile, the hospital is also expected to see an investment of Rs 100 crore in upgradation efforts, including the procurement of hi-tech equipment.

Funds would come from the Rs 500-crore kitty at its disposal, he said.

More Stories on : Health | Medical Institutions & Hospitals | Security

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
UP, Bihar, Orissa, MP drag down GDP growth


`India's rise is in everyone's interest'
DCGI approves drug for Kala-Azar
Stem-cells research and therapy on armed forces' radar
Dr Lal PathLabs opens in Bangalore
Minimum value addition norm for jewellery exports cut
India likely to resume tea talks with Pakistan soon


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line